BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Zhou Y, Liu Q, Xu J, Ma Y. Prognostic value of SOX2, Cyclin D1, P53, and ki-67 in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2018;11:5171-81. [PMID: 30210237 DOI: 10.2147/OTT.S160066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chai Y, Li Q, Zhao H, Zhang Z, Yu X, Pang L, Liu Z, Zhao J, Wang L, Li F. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma. Cancer Med 2019;8:7055-64. [PMID: 31560173 DOI: 10.1002/cam4.2569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Xu Y, Zhao H, Tong Y, Wang W, Huang J, Zhu W. Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus. Int J Gen Med 2021;14:3929-39. [PMID: 34345181 DOI: 10.2147/IJGM.S314054] [Reference Citation Analysis]
3 Bai L, Yan L, Guo Y, He L, Sun Z, Cao W, Lu J, Mo S. Perineural Invasion Is a Significant Indicator of High Malignant Degree and Poor Prognosis in Esophageal Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:816270. [PMID: 35756642 DOI: 10.3389/fonc.2022.816270] [Reference Citation Analysis]
4 Chen YT, Xie JY, Sun Q, Mo WJ. Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking. Int J Oncol 2019;54:152-66. [PMID: 30387840 DOI: 10.3892/ijo.2018.4618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Ye Z, Fang J, Wang Z, Wang L, Li B, Liu T, Wang Y, Hua J, Wang F, Fu Z. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma. Biosci Rep 2020;40:BSR20201727. [PMID: 32662828 DOI: 10.1042/BSR20201727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen A, Santana AL, Doudican N, Roudiani N, Laursen K, Therrien JP, Lee J, Felsen D, Carucci JA. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS One 2020;15:e0241551. [PMID: 33227008 DOI: 10.1371/journal.pone.0241551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ye X, Xie G, Liu Z, Tang J, Cui M, Wang C, Guo C, Tang J. TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy. Med Sci Monit 2020;26:e922703. [PMID: 32946432 DOI: 10.12659/MSM.922703] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Song Q, Liu H, Li C, Liang H. miR-33a-5p inhibits the progression of esophageal cancer through the DKK1-mediated Wnt/β-catenin pathway. Aging (Albany NY) 2021;13:20481-94. [PMID: 34426559 DOI: 10.18632/aging.203430] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Javaeed A, Ghauri SK. Metastatic potential and prognostic significance of SOX2: A meta-analysis. World J Clin Oncol 2019; 10(6): 234-246 [PMID: 31367532 DOI: 10.5306/wjco.v10.i6.234] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]